GSK
818 hedge funds and large institutions have $11.1B invested in GSK in 2020 Q4 according to their latest regulatory filings, with 112 funds opening new positions, 245 increasing their positions, 345 reducing their positions, and 106 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
1% less funds holding
Funds holding: 825 → 818 (-7)
18% less funds holding in top 10
Funds holding in top 10: 11 → 9 (-2)
29% less repeat investments, than reductions
Existing positions increased: 245 | Existing positions reduced: 345
Holders
818
Holding in Top 10
9
Calls
$105M
Puts
$98.5M
Top Buyers
| 1 | +$660M | |
| 2 | +$121M | |
| 3 | +$112M | |
| 4 |
Hotchkis & Wiley Capital Management
Los Angeles,
California
|
+$109M |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
+$77M |
Top Sellers
| 1 | -$149M | |
| 2 | -$103M | |
| 3 | -$98.8M | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$84.8M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$83.4M |